Search
Ocugen Inc
OCGNAdd to Watchlist
1.040USD
0.0000.00%
Close 10-06 16:00（ET）
352.06MMarket Cap
LossP/E TTM
Pre-market 08:08 (ET)1.040USD0.000
Pre-market 08:08 (ET)Ocugen Inc (OCGN) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Ocugen Inc in the past month.
Buy
1 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
12.167USD+1092.81%
OCGN Analyst Recommendation Trends
In the current month, OCGN has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OCGN average Analyst price target in the last month is 12.167.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
0
0
5
5
6
6
6
6
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
7
7
7
7
5
5
OCGN Analyst Rating for Peer Comparison
Updated: Oct 6, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, OCGN EPS is projected to reach -0.057 in FY2026Q3, following reported EPS of -0.073 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.06
-0.05
-0.05
-0.06
-0.06
Actual
-0.06
-0.06
-0.07
--
--
Surprise
+2.31%
-13.84%
-37.73%
--
--
FAQs
What is Ocugen Inc's expected revenue for the next quarter?
Ocugen Inc's expected revenue is 888.83K.
What is Ocugen Inc's price target?
Analysts forecast that Ocugen Inc's price target is USD 12.17, with the highest forecast at USD 22.00 and the lowest forecast at USD 8.00.
How have Ocugen IncOCGN's recent earnings per share performed?
The market expectation was USD -0.07, while Ocugen IncOCGN's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Ocugen Inc?
Based on the ratings of Ocugen Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.